Press Release
AMB302 Selected as Outstanding Project in KDDF Program
2024.12.10
- - AimedBio’s AMB302 was selected as an outstanding project at the 2024 Korean Drug Development Fund (KDDF) annual presentation.
- - Among 391 funded KDDF projects, only six were recognized as outstanding, highlighting the project’s high scientific and developmental merit.